Search research articles
Contact Us
Filters
Showing results (271-280 of 303) with videos related to
Page
of 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias
Judith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Blood Cancer Discovery
|
November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Cancer Research
|
January 8, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia
Husheng Ding, Nicole D Vincelette, Cordelia D McGehee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2018
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
Amer M Zeidan, Hanna A Knaus, Tara M Robinson, et al.
Haematologica
|
June 27, 2012
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Elizabeth Garrett-Mayer, Elihu H Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Rheumatology (Oxford, England)
|
September 6, 2016
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study
Murray Baron, Janet Pope, David Robinson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Blood
|
October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia
Judith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 303) with videos related to
Sort By:
Page
of 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias
Judith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Blood Cancer Discovery
|
November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Cancer Research
|
January 8, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia
Husheng Ding, Nicole D Vincelette, Cordelia D McGehee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2018
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
Amer M Zeidan, Hanna A Knaus, Tara M Robinson, et al.
Haematologica
|
June 27, 2012
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Elizabeth Garrett-Mayer, Elihu H Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Rheumatology (Oxford, England)
|
September 6, 2016
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study
Murray Baron, Janet Pope, David Robinson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Blood
|
October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia
Judith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Page
of 31